Community-Associated Methicillin-Resistant Staphylococcus aureus : Trends in Case and Isolate Characteristics from Six Years of Prospective Surveillance
Free accessResearch articleFirst published online May, 2009
Community-Associated Methicillin-Resistant Staphylococcus aureus : Trends in Case and Isolate Characteristics from Six Years of Prospective Surveillance
In 2000, the Minnesota Department of Health (MDH) implemented active, sentinel site surveillance for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Data from 2000–2005 were analyzed to determine trends in case characteristics, pulsed-field types (PFTs), and antimicrobial susceptibilities including inducible clindamycin resistance (ICR).
Methods.
Active sentinel site surveillance was initiated in 2000 at 12 hospital laboratories that served inpatients and outpatients. Patient medical records were reviewed to determine if they met the epidemiologic case criteria for CA-MRSA; isolates were obtained from patients meeting these criteria. The MDH Public Health Laboratory performed pulsed-field gel electrophoresis subtyping and antimicrobial susceptibility testing, including ICR.
Results.
The proportion of MRSA cases classified as CA increased from 11% to 33% (p<0.01). The proportion of cases with skin or soft tissue infections also increased compared with other infection types from 75% to 87% (p<0.01). During the surveillance period, USA300 replaced USA400 as the dominant PFT. With the change in dominant PFT, the proportion of isolates susceptible to erythromycin (45% to 13%, p<0.01) and ciprofloxacin (80% to 59%, p<0.01) decreased. The proportion of erythromycin-resistant/clindamycin-susceptible isolates with ICR (93% to 14%, p<0.01) decreased. The proportion of susceptible isolates also changed within the USA300 PFT; the proportion of isolates susceptible to erythromycin (33% vs. 3%) and the proportion susceptible to ciprofloxacin (67% to 62%) decreased significantly.
Conclusion.
CA-MRSA increased dramatically from 2000 to 2005. Changes in the predominant PFT have impacted susceptibility profiles of CA-MRSA, including ICR. Continued surveillance is needed to monitor the changing epidemiology of CA-MRSA and to inform clinical decisions.
AdcockPMPastorPMedleyFPattersonJEMurphyTV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis1998; 178:577–80.
10.
Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep1999; 48(32):707–10.
11.
FrankALMarcinakJFMangatPDSchreckenbergerPC. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis1999; 29:935–6.
12.
GorakEJYamadaSMBrownJD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis1999; 29:797–800.
13.
FergieJEPurcellK. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J2001; 20:860–3.
14.
MorinCAHadlerJL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis2001; 184:1029–34.
15.
ShahinRJohnsonILJamiesonFMcGeerATolkinJFord-JonesEL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med1999; 153:864–8.
16.
TurnidgeJDBellJM. Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years. Microb Drug Resist2000; 6:223–9.
BorerAAGiladJYagupskyPPeledNPoratNTreflerR, Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerg Infect Dis2002; 8:966–70.
19.
Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. MMWR Morb Mortal Wkly Rep2003; 52(33):793–5.
20.
Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, 2001–2003. MMWR Morb Mortal Wkly Rep2003; 52(41):992–6.
21.
LaMarJECarrRBZindermanCMcDonaldsK. Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Mil Med2003; 168:135–8.
22.
SaimanLO'KeefeMGrahamPLIIIWuFSaid-SalimBKreiswirthB, Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis2003; 37:1313–9.
23.
NaimiTSLeDellKHComo-SabettiKBorchardtSMBoxrudDJEtienneJ, Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA2003; 290:2976–84.
24.
HeroldBCImmergluckLEMarananMCLauderdaleDSGaskinREBoyle-VavraS, Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA1998; 279:593–8.
25.
HussainFMBoyle-VavraSBethelCDDaumRS. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infec Dis J2000; 19:1163–6.
LeClercqR. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis2002; 34:482–92.
28.
SiberryGKTekleTCarrollKDickJ. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis2003; 37:1257–60.
29.
McDougalLKStewardCDKillgoreGEChaitramJMcAllisterSKTenoverFC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol2003; 41:5113–20.
30.
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th ed. NCCLS document M7-A6. Wayne (PA): NCCLS; 2003.
31.
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 14th informational supplement. NCCLS document M100-S14. Wayne (PA): NCCLS; 2004.
32.
FiebelkornKRCrawfordSAMcElmeelMLJorgensenJH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol2003; 41:4740–4.
33.
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests; approved standard. 8th ed. NCCLS document M2-A8. Wayne (PA): NCCLS; 2003.
34.
Applied-Maths. Bionumerics: Version 5.1. St. Martens-Latem (Belgium): Applied-Maths; 2008.
35.
Centers for Disease Control and Prevention (US). Epi Info: Version 6.04c. Atlanta: CDC; 2001.
36.
BaggettHCHennessyTWLemanRHamlinCBrudenDReasonoverA, An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol2003; 24:397–402.
37.
BaggettHCHennessyTWRudolphKBrudenDReasonoverAParkinsonA, Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis2004; 189:1565–73.
38.
LemanRAlvarado-RamyFPocockSBargNKellumMMcAllisterS, Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population. Infect Control Hosp Epidemiol2004; 25:121–5.
39.
McCaigLFBesserREHughesJM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992–2000. Emerg Infect Dis2003; 9:432–7.
40.
Minnesota Department of Health. Community-associated methicillin-resistant Staphylococcus aureus in Minnesota. Disease Control Newsletter2004; 32:61–7.
41.
WatanakunakornC. Clindamycin therapy of Staphylococcus aureus endocarditis. Am J Med1976; 60:419–25.
42.
FrankALMarcinakJFMangatPDTjhioJTKelkarSSchreckenbergerPC, Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J2002; 21:530–4.
43.
LeeMCRiosAMAtenMFMejiasACavuotiDMcCrackenGHJr, Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J2004; 23:123–7.
44.
RuheJJSmithNBradsherRWMenonA. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis2007; 44:777–84.
45.
MoranGJKrishnadasanAGorwitzRJFosheimGEMcDougalLKCareyRB, Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med2006; 355:666–74.
